background participants

Participant 062


On this page, you will find information about a UDN participant.

Sharing information on this website is not a requirement of UDN participation. Only descriptions about participants who give explicit consent will appear here. While these participant pages are helpful to understand our participants’ stories, they do not begin to describe their diagnostic odysseys. A special thank you goes out to our participants and their families for sharing their experiences.

 

Male, age 56, with weakness, difficulty walking, polyneuropathy, seizure-like events, and cognitive decline

Date of Report

Apr 30, 2018

Description

The participant was healthy until age 15 when he had a surfing accident. This accident resulted in a brain injury and cervical spine fractures. A year after this accident, he began having seizures, but these resolved without treatment approximately a year later.

When the participant was 44 years old, he developed left-sided weakness and severe headaches. Over the course of the year, he began experiencing additional symptoms, such as numbness, muscle cramping, and episodes of vision loss. A brain MRI done at this time showed abnormalities (multiple small, scattered T2 white matter hyperintensities). Spine imaging revealed no lesions. He was diagnosed with probable multiple sclerosis and tried numerous therapies, including IV steroids, Rebif injections, Tysabri, and Aubagio. He had episodes of relapses throughout his IV steroid treatment. At age 53, the diagnosis of multiple sclerosis was questioned since he did not have brain and spinal cord lesions consistent with multiple sclerosis, there were no oligoclonal bands on cerebrospinal fluid, and he had a history of polyneuropathy.

Since then, the patient’s weakness, pain, and difficulty walking have increased. He has also been experiencing mild, but progressive, cognitive decline and seizure-like events.

Symptoms / Signs
  • Muscle weakness
  • Brain injury (left temporal lobe injury)
  • Abnormality of the brain (abnormality of the cerebral white matter) thought to be related to hypertension
  • Mental deterioration
  • Episodic transient visual loss
  • Difficulty walking (gait disturbance)
  • Stroke-like episode
  • Non-epileptic seizure-like events
  • Decreased muscle mass (skeletal muscle atrophy)
  • Damaged nerves (sensorimotor and constrictive median neuropathy)
  • Lazy eye (amblyopia)
  • Lung disease (chronic obstructive pulmonary disease) thought to be related to history of smoking
  • High arched foot (pes cavus)
  • Foot drop (foot dorsiflexor weakness)
  • Chronic pain
  • High blood pressure (hypertension)
Current Treatments
  • Diazepam – seizures
  • Hyoscyamine – muscle cramps
  • Ipratropium Bromide – chronic obstructive pulmonary disease
  • Morphine, oxycodone, Phenergan, Ondansetron – chronic pain
  • Quinapril – hypertension
Prior Treatments
  • IV steroids – muscle exacerbations
  • Rebif injections, Tysabri, Aubagio –  muscle weakness
  • Rituximab – autoimmune disease
Considered treatments
Previously Considered Diagnoses
  • Autoimmune condition
  • CADASIL syndrome
  • Charcot-Marie-Tooth disease
  • Chronic inflammatory demyelinating polyneuropathy
  • Lyme disease
  • Multiple sclerosis
Other Photographs
Genetic Variants of Interest
Contact

If this participant sounds like you or someone you know, please contact us!

Disclaimer

The information provided here is based on individual patient experiences. This information is not meant to substitute for advice of a qualified health care provider. Please do not use this information to diagnose or develop a treatment plan for a health problem or disease without consulting a qualified health care provider.

Any mention of products or services is not meant as a recommendation of the products or services. Please discuss any options with a qualified health care provider.

Developments in medical research may impact the information that appears here. No assurance can be given that the information in this site will include the most recent findings or developments.

The use of any information provided on this site is solely at your own risk.

Top